WEBULL

Should New Asian SLX Win and Repeat FPS Order Require Action From Mycronic (OM:MYCR) Investors?

Simply Wall St · 3d ago
  • In December 2025, Mycronic AB announced two Asian orders: an SLX laser mask writer from a new customer valued at US$5–7 million for delivery in early 2026, and an FPS 6100 Evo from an existing customer worth US$4–5 million for delivery in the third quarter of 2026.
  • Together, these orders highlight Mycronic’s ability to win both new and repeat business in semiconductor and multi-purpose photomask applications, reinforcing the relevance of its mask writer technology across several electronics end markets.
  • We will now examine how winning an SLX order from a new Asian customer could influence Mycronic’s existing investment narrative and risk balance.

These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Mycronic Investment Narrative Recap

To own Mycronic, I think you need to believe its mask writer franchise can keep attracting high value orders across displays, semiconductors and multi purpose applications, while managing cyclical swings in demand. The December 2025 SLX and FPS orders modestly support that view in the near term, but do not materially change the most important short term swing factor, which remains order intake volatility and delivery timing in the capital equipment cycle, nor the key risk around weaker demand and delayed investments in certain divisions.

Among the recent announcements, I see the 2025 guidance reaffirmation at SEK 7.5 billion of net sales as the most relevant reference point when thinking about these new mask writer orders. The SLX and FPS wins add visibility to future revenue, but they sit alongside earlier large display related orders and existing tariff and currency uncertainties, so investors may still want to focus on how consistently Mycronic can convert its order pipeline into realized sales and earnings.

Yet behind these encouraging orders, investors should be aware of the risk that hesitation in customer investments and weaker demand could still...

Read the full narrative on Mycronic (it's free!)

Mycronic's narrative projects SEK8.4 billion revenue and SEK1.8 billion earnings by 2028. This requires 1.3% yearly revenue growth and a SEK0.2 billion earnings decrease from SEK2.0 billion today.

Uncover how Mycronic's forecasts yield a SEK218.67 fair value, in line with its current price.

Exploring Other Perspectives

OM:MYCR 1-Year Stock Price Chart
OM:MYCR 1-Year Stock Price Chart

Three Simply Wall St Community fair value estimates cluster between SEK 214.92 and SEK 232.58 per share, showing how differently individual investors view Mycronic. Against that spread of opinions, recent order wins sit alongside ongoing risks around weaker High Flex demand and delayed customer investments, which could influence how the business performs over time.

Explore 3 other fair value estimates on Mycronic - why the stock might be worth as much as SEK232.58!

Build Your Own Mycronic Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Mycronic research is our analysis highlighting 3 key rewards that could impact your investment decision.
  • Our free Mycronic research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Mycronic's overall financial health at a glance.

Curious About Other Options?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.